UniProt ID | UFC1_HUMAN | |
---|---|---|
UniProt AC | Q9Y3C8 | |
Protein Name | Ubiquitin-fold modifier-conjugating enzyme 1 | |
Gene Name | UFC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 167 | |
Subcellular Localization | ||
Protein Description | E2-like enzyme which forms an intermediate with UFM1 via a thioester linkage.. | |
Protein Sequence | MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEFDIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQHKEKCNQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MADEATRR -------CCHHHHHH | 10.80 | - | |
17 | Ubiquitination | VSEIPVLKTNAGPRD HHCCCEECCCCCCCC | 39.71 | 32015554 | |
33 | Acetylation | ELWVQRLKEEYQSLI HHHHHHHHHHHHHHH | 51.17 | 23749302 | |
33 | Ubiquitination | ELWVQRLKEEYQSLI HHHHHHHHHHHHHHH | 51.17 | 23000965 | |
33 | Ubiquitination | ELWVQRLKEEYQSLI HHHHHHHHHHHHHHH | 51.17 | 21890473 | |
36 | Phosphorylation | VQRLKEEYQSLIRYV HHHHHHHHHHHHHHH | 12.42 | 22817900 | |
38 | Phosphorylation | RLKEEYQSLIRYVEN HHHHHHHHHHHHHHH | 25.51 | 24719451 | |
42 | Phosphorylation | EYQSLIRYVENNKNA HHHHHHHHHHHCCCC | 12.72 | 22817900 | |
47 | Ubiquitination | IRYVENNKNADNDWF HHHHHHCCCCCCCCE | 66.16 | 29967540 | |
60 | Ubiquitination | WFRLESNKEGTRWFG CEEEEECCCCCEEEE | 67.79 | 33845483 | |
68 | Ubiquitination | EGTRWFGKCWYIHDL CCCEEEEEEEEHHHH | 16.48 | 32015554 | |
114 | Ubiquitination | AKMYRGGKICLTDHF EEEECCCEEEECCCC | 32.82 | 29967540 | |
114 | Acetylation | AKMYRGGKICLTDHF EEEECCCEEEECCCC | 32.82 | 25953088 | |
116 | S-nitrosocysteine | MYRGGKICLTDHFKP EECCCEEEECCCCHH | 3.69 | - | |
116 | S-nitrosylation | MYRGGKICLTDHFKP EECCCEEEECCCCHH | 3.69 | 19483679 | |
118 | Phosphorylation | RGGKICLTDHFKPLW CCCEEEECCCCHHHH | 24.02 | 25159151 | |
122 | Acetylation | ICLTDHFKPLWARNV EEECCCCHHHHHCCC | 35.46 | 21791702 | |
122 | Ubiquitination | ICLTDHFKPLWARNV EEECCCCHHHHHCCC | 35.46 | 22817900 | |
122 | Ubiquitination | ICLTDHFKPLWARNV EEECCCCHHHHHCCC | 35.46 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UFC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UFC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UFC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UFM1_HUMAN | UFM1 | physical | 15071506 | |
UFM1_HUMAN | UFM1 | physical | 22939629 | |
VATF_HUMAN | ATP6V1F | physical | 22939629 | |
UNK_HUMAN | UNK | physical | 22939629 | |
ZPR1_HUMAN | ZPR1 | physical | 22939629 | |
USP9X_HUMAN | USP9X | physical | 22939629 | |
ANCHR_HUMAN | ZFYVE19 | physical | 22939629 | |
VATB2_HUMAN | ATP6V1B2 | physical | 22939629 | |
ZYX_HUMAN | ZYX | physical | 22939629 | |
VINC_HUMAN | VCL | physical | 22939629 | |
UFM1_HUMAN | UFM1 | physical | 24966333 | |
CATA_HUMAN | CAT | physical | 26344197 | |
COX17_HUMAN | COX17 | physical | 26344197 | |
ETFA_HUMAN | ETFA | physical | 26344197 | |
FKB1A_HUMAN | FKBP1A | physical | 26344197 | |
LDHB_HUMAN | LDHB | physical | 26344197 | |
LYPA2_HUMAN | LYPLA2 | physical | 26344197 | |
NECP2_HUMAN | NECAP2 | physical | 26344197 | |
NEDD8_HUMAN | NEDD8 | physical | 26344197 | |
TAGL2_HUMAN | TAGLN2 | physical | 26344197 | |
TALDO_HUMAN | TALDO1 | physical | 26344197 | |
UFM1_HUMAN | UFM1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-122, AND MASS SPECTROMETRY. |